Logo image of JBGS

JBG SMITH PROPERTIES (JBGS) Stock Fundamental Analysis

NYSE:JBGS - New York Stock Exchange, Inc. - US46590V1008 - REIT - Currency: USD

17.58  +0.48 (+2.81%)

After market: 17.58 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to JBGS. JBGS was compared to 129 industry peers in the Diversified REITs industry. JBGS may be in some trouble as it scores bad on both profitability and health. JBGS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year JBGS has reported negative net income.
JBGS had a positive operating cash flow in the past year.
In the past 5 years JBGS reported 4 times negative net income.
JBGS had a positive operating cash flow in each of the past 5 years.
JBGS Yearly Net Income VS EBIT VS OCF VS FCFJBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

JBGS has a worse Return On Assets (-3.36%) than 79.84% of its industry peers.
The Return On Equity of JBGS (-10.11%) is worse than 76.74% of its industry peers.
JBGS's Return On Invested Capital of 0.01% is on the low side compared to the rest of the industry. JBGS is outperformed by 88.37% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JBGS is below the industry average of 3.15%.
Industry RankSector Rank
ROA -3.36%
ROE -10.11%
ROIC 0.01%
ROA(3y)-0.99%
ROA(5y)-1.07%
ROE(3y)-2.88%
ROE(5y)-2.7%
ROIC(3y)0.37%
ROIC(5y)N/A
JBGS Yearly ROA, ROE, ROICJBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6 -8

1.3 Margins

Looking at the Operating Margin, with a value of 0.15%, JBGS is doing worse than 88.37% of the companies in the same industry.
In the last couple of years the Operating Margin of JBGS has declined.
JBGS has a worse Gross Margin (49.55%) than 77.52% of its industry peers.
In the last couple of years the Gross Margin of JBGS has remained more or less at the same level.
Industry RankSector Rank
OM 0.15%
PM (TTM) N/A
GM 49.55%
OM growth 3YN/A
OM growth 5Y-29.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5Y-0.13%
JBGS Yearly Profit, Operating, Gross MarginsJBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JBGS is destroying value.
JBGS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for JBGS has been reduced compared to 5 years ago.
The debt/assets ratio for JBGS is higher compared to a year ago.
JBGS Yearly Shares OutstandingJBGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
JBGS Yearly Total Debt VS Total AssetsJBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.07, we must say that JBGS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.07, JBGS is doing worse than 73.64% of the companies in the same industry.
A Debt/Equity ratio of 1.60 is on the high side and indicates that JBGS has dependencies on debt financing.
JBGS's Debt to Equity ratio of 1.60 is on the low side compared to the rest of the industry. JBGS is outperformed by 64.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Altman-Z 0.07
ROIC/WACC0
WACC6.48%
JBGS Yearly LT Debt VS Equity VS FCFJBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

JBGS has a Current Ratio of 1.87. This is a normal value and indicates that JBGS is financially healthy and should not expect problems in meeting its short term obligations.
JBGS's Current ratio of 1.87 is fine compared to the rest of the industry. JBGS outperforms 77.52% of its industry peers.
A Quick Ratio of 1.87 indicates that JBGS should not have too much problems paying its short term obligations.
JBGS has a Quick ratio of 1.87. This is in the better half of the industry: JBGS outperforms 77.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.87
JBGS Yearly Current Assets VS Current LiabilitesJBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

0

3. Growth

3.1 Past

JBGS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.89%.
Looking at the last year, JBGS shows a very negative growth in Revenue. The Revenue has decreased by -12.35% in the last year.
JBGS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.32% yearly.
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-4.8%
Revenue growth 5Y-3.32%
Sales Q2Q%-1.59%

3.2 Future

Based on estimates for the next years, JBGS will show a very negative growth in Earnings Per Share. The EPS will decrease by -16.02% on average per year.
JBGS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.01% yearly.
EPS Next Y-43.63%
EPS Next 2Y-16.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.02%
Revenue Next 2Y-3.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
JBGS Yearly Revenue VS EstimatesJBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
JBGS Yearly EPS VS EstimatesJBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5 -2

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JBGS. In the last year negative earnings were reported.
Also next year JBGS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBGS Price Earnings VS Forward Price EarningsJBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

79.07% of the companies in the same industry are cheaper than JBGS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.77
JBGS Per share dataJBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as JBGS's earnings are expected to decrease with -16.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.02%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

JBGS has a Yearly Dividend Yield of 4.06%, which is a nice return.
JBGS's Dividend Yield is slightly below the industry average, which is at 6.68.
Compared to an average S&P500 Dividend Yield of 2.38, JBGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.06%

5.2 History

The dividend of JBGS decreases each year by -7.39%.
JBGS has been paying a dividend for over 5 years, so it has already some track record.
JBGS has decreased its dividend recently.
Dividend Growth(5Y)-7.39%
Div Incr Years1
Div Non Decr Years1
JBGS Yearly Dividends per shareJBGS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of JBGS are negative and hence is the payout ratio. JBGS will probably not be able to sustain this dividend level.
The Dividend Rate of JBGS has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-38.25%
EPS Next 2Y-16.02%
EPS Next 3YN/A
JBGS Yearly Income VS Free CF VS DividendJBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

JBG SMITH PROPERTIES

NYSE:JBGS (6/2/2025, 8:11:40 PM)

After market: 17.58 0 (0%)

17.58

+0.48 (+2.81%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-28 2025-07-28
Inst Owners96.23%
Inst Owner Change-2.53%
Ins Owners0.05%
Ins Owner Change1.19%
Market Cap1.28B
Analysts42.5
Price Target15.3 (-12.97%)
Short Float %15.26%
Short Ratio8.23
Dividend
Industry RankSector Rank
Dividend Yield 4.06%
Yearly Dividend0.69
Dividend Growth(5Y)-7.39%
DP-38.25%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-08 2025-05-08 (0.175)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-58.24%
Min EPS beat(2)-85.76%
Max EPS beat(2)-30.72%
EPS beat(4)2
Avg EPS beat(4)-17.67%
Min EPS beat(4)-85.76%
Max EPS beat(4)35.44%
EPS beat(8)4
Avg EPS beat(8)-25.45%
EPS beat(12)6
Avg EPS beat(12)96.98%
EPS beat(16)9
Avg EPS beat(16)75.43%
Revenue beat(2)0
Avg Revenue beat(2)-13.59%
Min Revenue beat(2)-16.03%
Max Revenue beat(2)-11.15%
Revenue beat(4)0
Avg Revenue beat(4)-11.47%
Min Revenue beat(4)-17.51%
Max Revenue beat(4)-1.2%
Revenue beat(8)1
Avg Revenue beat(8)-8.71%
Revenue beat(12)1
Avg Revenue beat(12)-8.74%
Revenue beat(16)2
Avg Revenue beat(16)-5.98%
PT rev (1m)0%
PT rev (3m)-3.23%
EPS NQ rev (1m)-8%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.52%
EPS NY rev (3m)-26.22%
Revenue NQ rev (1m)-6.28%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.46
P/FCF N/A
P/OCF 12.2
P/B 0.82
P/tB 0.84
EV/EBITDA 17.77
EPS(TTM)-1.87
EYN/A
EPS(NY)-1.98
Fwd EYN/A
FCF(TTM)-1.28
FCFYN/A
OCF(TTM)1.44
OCFY8.2%
SpS7.16
BVpS21.51
TBVpS20.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.36%
ROE -10.11%
ROCE 0.02%
ROIC 0.01%
ROICexc 0.01%
ROICexgc 0.01%
OM 0.15%
PM (TTM) N/A
GM 49.55%
FCFM N/A
ROA(3y)-0.99%
ROA(5y)-1.07%
ROE(3y)-2.88%
ROE(5y)-2.7%
ROIC(3y)0.37%
ROIC(5y)N/A
ROICexc(3y)0.39%
ROICexc(5y)N/A
ROICexgc(3y)0.4%
ROICexgc(5y)N/A
ROCE(3y)0.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-29%
ROICexc growth 3YN/A
ROICexc growth 5Y-29.03%
OM growth 3YN/A
OM growth 5Y-29.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5Y-0.13%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Debt/EBITDA 12.12
Cap/Depr 96.68%
Cap/Sales 38.09%
Interest Coverage 0.01
Cash Conversion 50.92%
Profit Quality N/A
Current Ratio 1.87
Quick Ratio 1.87
Altman-Z 0.07
F-Score4
WACC6.48%
ROIC/WACC0
Cap/Depr(3y)148.41%
Cap/Depr(5y)152.09%
Cap/Sales(3y)54.34%
Cap/Sales(5y)56.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250%
EPS Next Y-43.63%
EPS Next 2Y-16.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-4.8%
Revenue growth 5Y-3.32%
Sales Q2Q%-1.59%
Revenue Next Year-5.02%
Revenue Next 2Y-3.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.14%
EBIT growth 3YN/A
EBIT growth 5Y-31.53%
EBIT Next Year2213.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y64.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.27%
OCF growth 3Y-15.91%
OCF growth 5Y-5.75%